Neuroprotectants in the treatment of stroke - An overview

Journal of Stroke and Cerebrovascular Diseases

Volumn 9, Issue 6, 2000, Pages 32-35

  Wahlgren, Nils Gunnar ^a,b   Lyden, Patrick ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Cerebral ischemia; Clomethiazole; Neuroprotection; Stroke; Thrombolysis

Indexed keywords

CLOMETHIAZOLE; FIBRINOLYTIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; TISSUE PLASMINOGEN ACTIVATOR;

BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COST OF ILLNESS; DAILY LIFE ACTIVITY; DRUG EFFECT; HUMAN; LONG TERM CARE; NEUROPROTECTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SIDE EFFECT;

EID: 0033652266     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2000.19320     Document Type: Review

References (25)

1. Finding new drugs to treat stroke
2. Lifetime cost of stroke in the United States
3. Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil
4. Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species
5. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischemia in the rat
6. The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia
7. The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat
8. Clomethiazole acute stroke study (CLASS): Results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients
9. An open study of clomethiazole in patients with acute cerebral infarction
10. Multicenter trial of hemodilution in acute ischemic stroke. I. Results in the total patient population
11. Functional evaluation: The Barthel Index
12. The Clomethiazole Acute Stroke Study (CLASS): Efficacy results in a subgroup of 545 patients with total anterior circulation syndrome
13. The Clomethiazole Acute Stroke Study in ischemic, hemorrhagic and t-PA treated stroke: Design of a Phase III trial in the United States and Canada
14. Thrombolysis for acute ischaemic stroke
15. Tissue plasminogen activator for acute ischemic stroke
16. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
17. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
18. Interobserver agreement for the assessment of handicap in stroke patients
19. Use of Barthel index and modified Rankin scale in acute stroke trials
20. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2
21. Management of acute myocardial infarction. Synopsis of ACC and AHA practice guidelines
22. ACC/AHA Guidelines for the management of patients with acute myocardial infarction
23. Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients